Seminars in Radiation Oncology

Papers
(The median citation count of Seminars in Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer40
Biology of Radiation-Induced Lung Injury32
Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer29
The Radiobiology of Radiopharmaceuticals24
Biology of HPV Mediated Carcinogenesis and Tumor Progression23
Epidemiology of HPV Related Malignancies23
Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies22
The Role of Theranostics in Prostate Cancer21
Automated Radiation Treatment Planning for Cervical Cancer20
Regulatory Aspects of the Use of Artificial Intelligence Medical Software17
Quality Assurance for AI-Based Applications in Radiation Therapy16
Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy16
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology16
Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies14
Automated Tumor Segmentation in Radiotherapy14
Meeting the Global Need for Radiation Therapy in Cervical Cancer—An Overview14
Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations13
Radiopharmaceuticals for Neuroendocrine Tumors13
Chromosome Missegregation as a Modulator of Radiation Sensitivity12
Knowledge-Based Planning for Intact Cervical Cancer12
Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients12
Radiopharmaceutical Chemistry and Drug Development—What's Changed?12
Theranostics: The Role of Quantitative Nuclear Medicine Imaging10
Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC10
Targeting Non-homologous and Alternative End Joining Repair to Enhance Cancer Radiosensitivity10
Imaging and its Impact on Defining the Oligometastatic State9
Re-Irradiation of Recurrent Non-Small Cell Lung Cancer9
Novel Agents and Future Perspectives on Theranostics9
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets9
DCIS: Risk Assessment in the Molecular Era8
The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade8
The Biological Process of Aging and the Impact of Ionizing Radiation8
Uncertainty Assessment for Deep Learning Radiotherapy Applications8
Challenges in Re-Irradiation in the Thorax: Managing Patients with Locally Recurrent Non-Small Cell Lung Cancer8
Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date8
Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer7
Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations7
Intensified Systemic Therapy Regimens in Combination With Definitive Radiation for Treatment of Cervical Cancer7
The Spectrum of Metastasis: An Opportunity for Cure?7
The Medical Physics Management of Reirradiation Patients6
Radiation and Modulation of the Tumor Immune Microenvironment in Non–Small Cell Lung Cancer6
Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence6
Radiopharmaceuticals for Bone Metastases6
Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology6
Artificial Intelligence for Image Registration in Radiation Oncology6
Artificial Intelligence for Outcome Modeling in Radiotherapy6
Balancing Fractionation and Advanced Technology in Consideration of Reirradiation6
Incorporating Magnetic Resonance Imaging (MRI) Based Radiation Therapy Response Prediction into Clinical Practice for Locally Advanced Cervical Cancer Patients6
Aiming for 100% Local Control in Locally Advanced Cervical Cancer: The Role of Complex Brachytherapy Applicators and Intraprocedural Imaging6
Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC6
Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape6
Regional Nodal Management in the Setting of Up-Front Surgery5
Seeing is Believing: State of the Art Imaging of Bladder Cancer5
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology5
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation5
Hypofractionation in Early Stage Non-Small Cell Lung Cancer5
Prevention and Screening of HPV Malignancies5
Future Directions in the Use of SAbR for the Treatment of Oligometastatic Cancers5
Mechanisms of Immune Modulation by Radiation5
Potential of Deep Learning in Quantitative Magnetic Resonance Imaging for Personalized Radiotherapy5
Tailoring the Omission of Radiotherapy for Early-Stage Breast Cancer Based on Tumor Biology5
Challenges in Reirradiation of Intrahepatic Tumors5
The Rapid Evolution of Theranostics in Radiation Oncology5
Immunotherapy for HPV Malignancies5
Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials4
Oligometastatic Breast Cancer4
Systemic Therapy for Mutation-Driven NSCLC4
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer4
Advances in Automated Treatment Planning4
Precision Radiation for Brain Metastases With a Focus on Hypofractionated Stereotactic Radiosurgery4
Artificial Intelligence and Deep Learning for Brachytherapy4
Hypoxia-Targeted Dose Painting in Radiotherapy4
Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm4
Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology4
The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North America3
Treatment Intensification in Locally Advanced/Unresectable NSCLC Through Combined Modality Treatment and Precision Dose Escalation3
Ethical Aspects of Artificial Intelligence in Radiation Oncology3
Radiopharmaceutical Delivery for Theranostics: Pharmacokinetics and Pharmacodynamics3
Introduction: Cervical Cancer3
Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer3
The Promise and Future of Radiomics for Personalized Radiotherapy Dosing and Adaptation3
Standardization of Artificial Intelligence Development in Radiotherapy3
Emerging Technologies in Mitigating the Risks of Cardiac Toxicity From Breast Radiotherapy3
Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?3
Emerging Paradigm of Consolidative Thoracic Radiotherapy in Oligometastatic NSCLC3
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials3
Radiation Treatment Deintensification for HPV-Associated Oropharyngeal Cancer3
Mechanisms, Challenges, and Opportunities in Combined Radiation and Hormonal Therapies3
Multimodality Treatment with Radiotherapy and Immunotherapy in Older Adults: Rationale, Evolving Data, and Current Recommendations3
Recognizing Frailty in Radiation Oncology Clinical Practice: Current Evidence and Future Directions3
Oncometabolites as Regulators of DNA Damage Response and Repair3
To Radiate or Not to Radiate—The Challenges of Pelvic Reirradiation3
0.020434141159058